Hormone antagonists

Name: Hormone antagonists
Brand: De Gruyter
Price: 219.0 EUR
Availability: OnlineOnly

M.K. Agarwal(Herausgeber*in)

De Gruyter (Verlag)

1. Auflage

Erschienen am 20. Mai 2019

IX, 732 Seiten

E-Book

PDF mit Wasserzeichen-DRM

Systemvoraussetzungen

978-3-11-150675-3 (ISBN)

219,00 €inkl. 7% MwSt.

Systemvoraussetzungen

für PDF mit Wasserzeichen-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Intro
PREFACE
CONTENTS
SECTION 1: STEROID HORMONE ANTAGONISTS
STEROID AGONISTS AND ANTAGONISTS: MOLECULAR CONFORMATION, RECEPTOR BINDING AND ACTIVITY
ANTIHORMONAL ACTIVITIES OF STEROIDS WITH MODIFIED RINGS A OR B
ANTAGONISM OF STEROID HORMONES BY SPECIFIC ANTIBODIES
ANTAGONISM OF STEROID HORMONE ACTION BY INTERFERENCE OF RECEPTOR FUNCTION WITH LOW MOLECULAR WEIGHT INHIBITORS
ANTI-STEROIDS AND ANIMAL BEHAVIOUR : A REVIEW
AGONISTIC AND ANTAGONISTIC PROPERTIES OF CLOMIPHENE
HYDROXYLATED ANTIOESTROGENS: NEW PHARMACOLOGICAL PROBES TO INVESTIGATE OESTROGEN AND ANTIOESTROGEN ACTION
Biological Actions and Binding Properties of a New Estrogen Antagonist
BINDING PROPERTIES AND LIGAND SPECIFICITY OF AN INTRACELLULAR BINDING SITE WITH SPECIFICITY FOR SYNTHETIC OESTROGEN ANTAGONISTS OF THE TRIPHENYLETHYLENE SERIES
ESTROGEN RECEPTOR BINDING PARAMETERS OF THE HIGH AFFINITY ANTIESTROGEN ⊃&3&/sup&H-H1285
POTENTIAL ANTIOESTROGENIC AND ANTITUMOUR MECHANISMS OF TAMOXIFEN ACTION IN BREAST CANCER
ANTI-TUMOR ACTION OF NON-STEROIDAL ANTIESTROGENS
PROGESTERONE INHIBITION OF NUCLEAR ESTROGEN RECEPTOR RETENTION
ADVANCES IN THE STUDY OF ANTIPROGESTATIONAL AGENTS
PHARMACOLOGICAL AND CLINICAL EFFECTS OF ANT IANDROGENS
MECHANISM OF ACTION OF A STEROIDAL ANTI-ANDROGEN TSAA-291, 16B-ETHYL-176-H YDROXYESTR-4-EN-3-ONE
STRUCTURE-AFFINITY RELATIONSHIP OF ANTIMINERALOCORTICOID ACTIVE STEROIDS
PROGESTIN ANTAGONISM OF ALDOSTERONE ACTION IN THE KIDNEY
CLINICAL PHARMACOLOGY AND THERAPEUTIC USE OF ALDOSTERONE ANTAGONISTS
ANTIGLUCOCORTICOIDS: DIFFERENTIAL ANTAGONISM OF IN VIVO RESPONSES TO DEXAMETHASONE
ANTAGONISM OF GLUCOCORTICOID ACTION IN VIVO
DISCRIMINATION BETWEEN GLUCOCORTICOID AGONISTS AND ANTAGONISTS BY MEANS OF RECEPTOR BINDING STUDIES
ANTAGONISM OF GLUCOCORTICOID ACTION BY INSULIN
INHIBITION OF ADRENAL STEROID BIOSYNTHESIS BY METYRAPONE
SECTION 2: PEPTIDE HORMONE ANTAGONISTS
STRUCTURAL, CONFORMATIONAL AND DYNAMIC CONSIDERATIONS IN THE DEVELOPMENT OF PEPTIDE HORMONE ANTAGONISTS
INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
ANTI-PROLACTIN AND ANTI-GROWTH HORMONE RECEPTOR ANTIBODIES, AND THEIR USE AS ANTI-HORMONAL AGENTS
CLINICAL APPLICATIONS OF PROLACTIN LOWERING DRUGS
RECEPTOR ANTAGONISTS OF THE ACTIONS OF GASTROINTESTINAL PEPTIDES ON PANCREATIC ACINAR CELLS
GASTHIN ANTAGONISM
ANTIGONADAL EFFECTS OF GONADOTROPIN-RELEASING HORMONE AND AGONIST ANALOGS
ANTAGONISTS OF HYPOTHALAMIC REGULATORY PEPTIDES AND DOPAMINE
LUTEINIZING HORMONE RELEASING HORMONE ANALOGS AS ANTIHORMONES
ANTIGONADOTROPIC, ANTISTEROIDOGENIC AND ANTISTEROIDAL ACTIVITIES OF AGONIST ANALOGS OF LUTEINIZING HORMONERELEASING HORMONE AS REVEALED BY THEIR ANTIREPRODUCTIVE ACTIVITIES
SECTION 3: MISCELLANEOUS HORMONES AND ANTAGONISTS
HORMONAL INHIBITION OF ADENYLATE CYCLASE: A POSSIBLE MECHANISM FOR PHYSIOLOGICAL ANTAGONISM
NALOXONE AND NALTREXONE: Endorphin Antihormones
ANTIHISTAMINES
X-RAY CRYSTALLOGRAPHIC STUDIES OF THYROID HORMONE, ANALOGUE AND COMPETITOR BINDING INTERACTIONS WITH HUMAN SERUM PREALBUMIN
ANTIPHEROMONES?
AUTHOR INDEX
SUBJECT INDEX

Systemvoraussetzungen

Als PDF speichern Als Link merken